Miromatrix Medical Inc. (MIRO)

Miromatrix Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019
Cash & Equivalents	6.01	53.61	4.44	3.25
Short-Term Investments	19.99	0	0	0
Cash & Cash Equivalents	26	53.61	4.44	3.25
Cash Growth	-51.51%	1106.28%	36.75%	-
Receivables	0.93	1.27	0.12	0.53
Other Current Assets	0.38	0.45	0.13	0.1
Total Current Assets	27.31	55.34	4.69	3.87
Property, Plant & Equipment	7.22	5.59	0.32	0.37
Long-Term Investments	0	0	0.24	3.48
Other Long-Term Assets	0.23	0	0	0.03
Total Long-Term Assets	7.45	5.59	0.56	3.87
Total Assets	34.76	60.93	5.25	7.75
Accounts Payable	1.58	2.09	0.13	0.3
Deferred Revenue	1.47	0.98	0.49	0
Current Debt	0.43	0.39	6.41	0.26
Other Current Liabilities	1.46	1.1	1.13	1.06
Total Current Liabilities	4.95	4.56	8.16	1.62
Long-Term Debt	3.12	0.44	0.93	0.87
Other Long-Term Liabilities	0.59	1.8	0.53	0.02
Total Long-Term Liabilities	3.71	2.24	1.46	0.89
Total Liabilities	8.66	6.8	9.63	2.52
Total Debt	3.55	0.83	7.34	1.14
Debt Growth	327.65%	-88.69%	545.28%	-
Common Stock	130.12	128.18	8.35	7.64
Retained Earnings	-104.01	-74.05	-59.38	-49.07
Shareholders' Equity	26.11	54.13	-51.03	-41.43
Net Cash / Debt	22.45	52.78	-2.9	2.11
Net Cash / Debt Growth	-57.47%	-	-	-
Net Cash Per Share	1.08	4.60	-1.34	1.03
Working Capital	22.36	50.77	-3.47	2.25
Book Value Per Share	1.26	4.71	-23.57	-20.28

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).